Wungki Park, Anup Kasi, Jonathan W. Goldman, Meredith Pelster, Benjamin Herzberg, Anthony W. Tolcher, Alexander I. Spira, Antoine Hollebecque, Hirokazu Shoji, Yasutoshi Kuboki, Judy S. Wang, Jordan Berlin, Shilpa Kadam, Ho-Jin Lee, Stanley Gill, Takeshi Saito, Joseph C. Poythress, Junko Toyoshima, Hisaki Fujii, Shigehisa Kitano. "Phase 1 evaluation of ASP3082, a first-in-class selective protein degrader, in patients (pts) with
                    <i>KRAS G12D</i>
                    -mutant pancreatic ductal adenocarcinoma (PDAC): Pharmacokinetics (PK) and biomarker insights.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.2_suppl.775